Understanding how autophagy affects the start of sperm development
Defining the Mechanism of Meiotic Initiation Through Autophagy Pathway
This study is looking at how a process in our cells called autophagy affects the start of sperm development, focusing on a protein that helps control this process, and it aims to find new ways to understand and possibly improve male fertility.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10870114 on NIH RePORTER |
What this research studies
This research investigates the role of autophagy, a cellular process that degrades proteins and organelles, in the initiation of meiosis, which is crucial for sperm development. The study focuses on a specific protein, STRA8, that appears to suppress autophagy, allowing the accumulation of proteins necessary for the activation of meiotic genes. By exploring the relationship between autophagy and meiotic initiation, the research aims to uncover new molecular mechanisms that could influence male fertility. Patients may benefit from insights gained about male infertility and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are men experiencing infertility issues related to poor sperm quantity or quality.
Not a fit: Patients who are not experiencing male infertility or have other unrelated reproductive health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for male infertility by identifying novel pathways that regulate sperm development.
How similar studies have performed: While the specific link between autophagy and meiotic initiation is novel, similar research has shown that understanding cellular processes can lead to breakthroughs in fertility treatments.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Wang, Ning — University of Kansas Medical Center
- Study coordinator: Wang, Ning
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.